Target intelligence / Profile preview

Multiple bacterial macromolecules

Molecular classification
Other
01

Overview

Multiple bacterial macromolecules is a collective term used to describe the diverse array of essential cellular components—including proteins, nucleic acids, and lipids—that are targeted by broad-spectrum antimicrobial agents (DrugBank, DB06812). This target designation is typically used for antiseptics and disinfectants that do not bind to a single specific receptor or enzyme but instead exert their effects through rapid, multi-site chemical reactions such as oxidation, alkylation, or denaturation (StatPearls, "Antiseptics and Disinfectants"). By simultaneously damaging various structural and functional molecules, these agents disrupt vital processes including cell wall integrity, metabolic pathways, and genetic replication, leading to rapid cell death (PubMed, PMID: 15479116). This multi-target approach is highly effective against a wide spectrum of pathogens and significantly reduces the likelihood of resistance development, as it would require multiple simultaneous mutations to bypass the damage (NIH, "Mechanism of Action of Microbicides"). However, the inherent lack of selectivity means these agents can also damage host tissues, which generally restricts their clinical use to topical applications or environmental sterilization (PubChem, CID 713).

Other names
Bacterial cell componentsMultiple bacterial targetsBacterial cellular constituentsBacterial biomass
02

Mechanism of action

Non-specific disruption of bacterial cellular integrity through oxidation, protein denaturation, and covalent modification of nucleic acids and lipids.

03

Biological functions

DNA replicationProtein synthesisCell wall synthesisMetabolismOther
04

Disease associations

InfectionSepsis
05

Safety considerations

Cytotoxicity to host tissuesLocal irritationSystemic toxicity upon absorptionHypersensitivity reactions
06

Interacting drugs

Povidone-iodine

6 more in the full profile.

07

Biomarkers

Bacterial loadC-reactive protein (CRP)Procalcitonin

Beyond the preview

Go deeper on Multiple bacterial macromolecules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple bacterial macromolecules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call